ArticleCancers2020

Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer.

Maria Karmella Apaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.